Core Viewpoint - The sudden discontinuation of the Alzheimer's drug, 甘露特钠胶囊 (brand name "九期一"), by Green Valley Pharmaceutical has led to a crisis for patients relying on this medication, with reports of counterfeit drugs flooding the market as a result of the supply shortage [1][2][4]. Group 1: Drug Supply Crisis - The discontinuation of 甘露特钠胶囊 began in early May 2025 and peaked in June, leaving many families of Alzheimer's patients in desperate search for alternatives [1][2]. - Green Valley Pharmaceutical stated that the production halt was due to the expiration of the drug's registration certificate, which is currently awaiting review [4]. Group 2: Counterfeit Drug Market - The shortage of the legitimate drug has led to a surge in counterfeit products being sold online, with misleading names such as "同仁堂甘露特钠胶囊" and "甘露药食同源浓缩丸" appearing on e-commerce platforms [6][11]. - Prices for the legitimate drug have skyrocketed, with reports of it being sold for as much as 5000 yuan per box, compared to the original monthly cost of approximately 296 yuan after insurance [4][2]. Group 3: Brand Misuse and Legal Issues - The issue of brand misuse is not new for 同仁堂, which previously reported 65 instances of its name being used fraudulently in March 2025 [11]. - The sale of counterfeit drugs has been identified as a criminal offense, with a notable case in May 2024 involving a live-streaming fraud scheme that targeted older adults, resulting in a financial loss of 30.89 million yuan [13].

Core Viewpoint - The rapid development of live e-commerce has led to the promotion of ordinary food products as "health miracle drugs," with hosts using carefully crafted scripts to induce viewers to make purchases [1][6][18] Group 1: Misleading Product Claims - Many products, such as a tea claimed to be from Beijing Tongrentang, are marketed with exaggerated health benefits like "lowering blood pressure" and "improving stroke paralysis," despite containing spelling errors on their packaging [1][10] - A product marketed as γ-aminobutyric acid collagen peptide drink is promoted with claims of containing "4 major amino acids + 13 nutrients" and having growth-enhancing effects, while its actual standard is that of a beverage, not a health supplement [6][7] - The promotion of products like "shark cartilage calcium tablets" and "glucosamine chondroitin" as traditional medicinal materials is misleading, as they are merely pressed candy [1][12] Group 2: Regulatory Challenges - Despite ongoing improvements in management measures for live e-commerce, many continue to blur the lines in the "three products and one device" (medicines, medical devices, health foods, and special medical purpose formula foods) sector, making it difficult for consumers to identify exaggerated claims [2][19] - Regulatory authorities face challenges in taking action against misleading claims due to a lack of medical knowledge, which hampers their ability to intervene effectively [2][19] Group 3: Legal Consequences - A case in Anhui Province involved a company that falsely marketed a health product, resulting in a sales amount exceeding 30 million yuan, leading to significant prison sentences for the perpetrators [13][16] - The market supervision department reported a significant increase in complaints related to live e-commerce, with 402,000 complaints received in 2024, marking a 19.3% year-on-year increase [12] Group 4: Industry Insights - Analysts highlight that the most significant issues in the live e-commerce sector include false advertising, the strong concealment of misleading claims, and the lack of substantial penalties for violations, which fails to deter those attempting to exploit loopholes [18][19] - Recommendations for industry governance include requiring that only qualified professionals and institutions engage in live e-commerce for health-related products, with strict penalties for violations [19]